Viatris says reached 'agreement' to resolve UK litigation risk over perindopril
( November 6, 2026, 16:29 GMT | Official Statement) -- MLex Summary: Viatris has "reached an agreement in principle to resolve" its involvement in UK antitrust litigation from health authorities over the supply of blood pressure drug perindopril, the company said in a US Securities and Exchange Commission filing. The dispute stems from 2014, when generic drug makers were fined by the EU antitrust regulator over their practices.Filing attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.